Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigator-Initiated Feasibility Study of a Novel Endoscopic Ultrasound Guided Microwave Ablation Device in Patients With Locally Advanced, Unresectable, or Metastatic Cancer

NCT07817147 is registered in ClinicalTrials.gov with Banner Health as lead sponsor.

NCT NCT07817147
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07817147 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigator-Initiated Feasibility Study of a Novel Endoscopic Ultrasound Guided Microwave Ablation Device in Patients With Locally Advanced, Unresectable, or Metastatic Cancer
Lead sponsor
Banner Health
Phase
Not applicable
Overall status
Recruiting
Start date
February 19, 2026
Completion date
August 31, 2028
Enrollment
75 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

liver cancer (locally advanced or metastatic), liver cancer stage iiia, liver cancer stage iiib, liver cancer stage iiic, liver cancer stage iv, pancreatic cancer, pancreatic cancer non-resectable, pancreatic cancer stage iii, pancreatic cancer stage iv